Epidemiology of Breast Cancer

  • Breast cancer is the most common type of cancer diagnosed in women:
    • Comprising 30% of all women’s cancer diagnoses in the United States:
      • The American Cancer Society estimates that:
        • 268,600 new cases of breast cancer will be diagnosed in women in 2019:
          • Along with about 2670 cases in men:
            • In addition 48,100 cases of DCIS will be diagnosed among women

        • After lung cancer:
          • Breast cancer is the second leading cause of cancer-related death in women:
            • Accounting for 15% of cancer-related deaths:
              • Approximately 41,760 women and 500 men:
                • Are expected to die from breast cancer in 2019


  • The incidence of breast cancer has consistently outpaced the incidence of all other cancers (excluding indolent cutaneous malignancies) in women in the US:
    • As of 2015:
      • The incidence rate of female breast cancer in the US was:
        • 124.8 per 100,000 population
    • Of note, the incidence of invasive breast cancers decreased between 1999 and 2004:
      • Which coincides with and is possibly attributable to:
        • Better adherence to recommended screening mammography for the general population of women
        • As well as decreasing use of menopausal hormone replacement therapy (HRT)


  • Worldwide:
    • Breast cancer is the leading cause of cancer death in women


  • Although the United States and Western Europe have a five-fold higher number of new cases of breast cancer compared with Africa and Asia:
    • Since 1990:
      • The death rate of breast cancer has declined by 24% in the United States (as well as other countries in Western Europe):
        • This may be due to:
          • Increased use of screening mammography
          • Much better adjuvant chemotherapy therapy


  • Given the high incidence and mortality of breast cancer:
    • Defining the risk factors for breast cancer has significant clinical value:
      • Physicians can use this information to work with patients to minimize modifiable factors, and to determine appropriate screening procedures


  • Rodrigo Arrangoiz MS, MD, FACS cirujano oncology y cirujano de mamá de Sociedad Quirúrgica S.C en el America British Cowdray Medical Center en la ciudad de Mexico:
    • Es experto en el manejo del cáncer de mama.

👉Es miembro de la American Society of Breast Surgeons:


• General surgery:

• Michigan State University:

• 2004 al 2010

• Surgical Oncology / Head and Neck Surgery / Endocrine Surgery:

• Fox Chase Cancer Center (Filadelfia):

• 2010 al 2012

• Masters in Science (Clinical research for health professionals):

• Drexel University (Filadelfia):

• 2010 al 2012

• Surgical Oncology / Head and Neck Surgery / Endocrine Surgery:

• IFHNOS / Memorial Sloan Kettering Cancer Center:

• 2014 al 2016










Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s